Compare tickers
Up to 5 tickers, ~30 metrics, weighted verdict. Best in green, worst in red.
Verdict
Weighted score 0-100 across 1 tickers · best in green
25
25
15
20
15
Total: 100 · normalized in scoring
#1
ARQT
score 50.0
Ranks first with balanced 50-across scores but weakest in momentum at negative 15.93% YTD despite strong 12.4% one-month gain.
value 50growth 50quality 50momentum 50sentiment 50
ARQT
Arcutis Biotherapeutics, Inc.
$24.38
-0.85%
ARQT
Arcutis Biotherapeutics, Inc.
$24.38
-0.85%
Snapshot
Price
24.38
Day %
-0.85
1M %
12.4
3M %
7.16
YTD %
-15.93
Market cap
3049532672.0
ADV ($)
38839776.66301727
Beta
1.521
OdysseyHQ zone
Current zone
Extended
Dist 21-EMA %
9.67
Dist ATR (σ)
1.97
OdysseyHQ grade
B
Confluence
4
Valuation
P/E (ttm)
—
P/E (fwd)
21.095257
P/S
7.3372393
EV/EBITDA
538.203
P/B
16.071194
FCF yield
0.0012
PEG
—
Growth
Revenue yoy
0.601
EPS yoy
—
FCF yoy
—
Quality
Gross margin
0.90942
Operating margin
-0.08623999
Net margin
-0.0057200002
ROE
-0.0143
ROA
0.0049900003
Debt / Equity
0.6
Interest cov.
-0.24
Technicals
RSI(14)
64.7
MACD signal
bull
vs 50-DMA
7.91
vs 200-DMA
2.48
vs 52w high
-23.26
HV-30
64.6
Sentiment
Analyst rec
1.5
Target upside
42.02
Insider buy-sell 90d
7
Risk
Short interest
13.84
Days to cover
7.62
Next earnings
2026-08-05
Full ARQT dashboard →